Immunome doses first patient in IM-3050 trial
Immunome (NASDAQ:IMNM) dosed the first patient in a Phase 1 trial of IM-3050 for FAP-expressing advanced solid tumours.
Immunome (NASDAQ:IMNM) dosed the first patient in a Phase 1 trial of IM-3050 for FAP-expressing advanced solid tumours.
IREN (NASDAQ:IREN) raised its year-end 2026 AI Cloud annualized run-rate revenue (ARR) target to over $4 billion, up from its previous target of $3.7 billion.
Highway Holdings (NASDAQ:HIHO) reported first-quarter fiscal 2027 revenue of approximately $2 million, representing a 29.2% increase compared to the same period last year.
GE Aerospace (NYSE:GE) announced at the Farnborough International Airshow that it has successfully conducted the world’s first hybrid electric flight above 30,000 feet.
Boeing (NYSE:BA) and Philippine Airlines announced that the flag carrier has committed to order up to 20 Boeing 787 Dreamliner jets.
IFF (NYSE:IFF) — a global leader in flavors, fragrances, and health and biosciences — announced that it has entered into an agreement with SuanNutra to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities.
Hut 8 (NASDAQ:HUT) announced the full commercialization of its 1 GW Beacon Point AI data center campus in Texas.
LXP Industrial Trust (NYSE:LXP) agreed to be acquired by a buyer group comprising Brookfield Asset Management and CPP Investments.
Domino's Pizza (NASDAQ:DPZ) reported second quarter 2026 total revenues of $1.19 billion, up 4.3% year over year.
UK Prime Minister Keir Starmer, in his last speech before stepping down, said he is closing the book on his time as premier. "My work is done," he added, standing outside No. 10 Downing Street.
Greenwich LifeSciences (NASDAQ:GLSI) amended its Phase III breast cancer trial, expecting a 2.22x overall enrollment increase.
Seer (NASDAQ:SEER) announced its Special Committee rejected a $2.45 per share acquisition proposal from CEO Omid Farokhzad.